Let a Thousand DNA Flowers Bloom
By KIM BELLARD When I saw a headline about “DNA flowers,” I was nonplused. I…
Let a Thousand DNA Flowers Bloom
By KIM BELLARD When I saw a headline about “DNA flowers,” I was nonplused. I mean: aren’t all flowers made out of DNA, like every living thing on our planet? Well, it turns out that the DNA flowers are actually soft robots – make that nanobots – so my interest was definitely piqued. The DNA…
7 HLTH Announcements You Don’t Want to Miss
As always, this year’s HLTH conference brought a slew of announcements — from product launches to funding rounds to new partnerships. This list features short summaries for seven of the conference’s most notable announcements. The post 7 HLTH Announcements You Don’t Want to Miss appeared first on MedCity News.
How to write a good grant proposal
How do you write a good grant proposal? How do you write a good proposal for any type of project? Jim Olds– the former head of NSF’s Biological Sciences Directorate –provides some fantastic advice in his post “What Grant Reviewers Actually Look For (and What They Ignore)“. He distills what grant reviewers want into 5…
Centene CEO: ICHRA Is the Future of Individual Health Insurance
During a Monday session at the HLTH Conference in Las Vegas, Centene CEO Sarah London shared her thoughts on ICHRA, calling it the “future of individual health insurance.” The post Centene CEO: ICHRA Is the Future of Individual Health Insurance appeared first on MedCity News.
Is Optum Real For Real?
Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group’s Optum subsidiary is hoping to change the dynamic through what they claim is a real-time claims management program leveraging tech. The post Is Optum Real For Real? appeared first on MedCity News.
Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm
In a placebo-controlled mid-stage study, Ventyx Biosciences’ oral NLRP3 inhibitor led to rapid and sustained reductions in levels of a protein that’s an indicator of cardiovascular disease risk. The brain-penetrating properties of this once-daily pill also have potential applications addressing inflammation that drives neurodegenerative disorders. The post Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set…
KFF Health News’ ‘What the Health?’: Nutrition Programs Face Their Own Shutdown
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Solving the Paper Crisis: Transforming Text Documents through AI
Data is beginning to be liberated from static documents—and that represents a sea change
Technology Evolution: Why Clinicians Must Expand Their Sources of Data
Healthcare today requires more than the partial snapshot offered by legacy technology. By integrating diverse data sources such as wearables, claims, communications, and ADT feeds, clinicians gain a comprehensive, real-time view of their patients’ health. The post Technology Evolution: Why Clinicians Must Expand Their Sources of Data appeared first on MedCity News.
Closing the Rural Divide with Device-enabled Virtual Care
Bringing care to people where they are improves community health outcomes — we must operate with more urgency to shore up care resources in rural areas. The post Closing the Rural Divide with Device-enabled Virtual Care appeared first on MedCity News.
